NAT10 and esophageal squamous cell carcinoma: In ESCC, ac4C modification by NAT10 enhances the RNA stability of the lipid metabolism-related gene fatty acid synthase (FASN) to induce macrophage M2 polarization, which can enhance the effect of PD-1 therapy [87].